This document specifies:
— the general principles governing the biological evaluation of medical devices within a risk
management process;
— the general categorization of medical devices based on the nature and duration of their contact with
the body;
— the evaluation of existing relevant data from all sources;
— the identification of gaps in the available data set on the basis of a risk analysis;
— the identification of additional data sets necessary to analyse the biological safety of t...
view more

    • sale 10% off
    • Standard
      50 pages
      English language
    • e-Library read for
      1 day
    • sale 10% off
    • Draft
      51 pages
      English language
    • e-Library read for
      1 day

This document specifies requirements and gives guidance on the procedures in the preparation of samples and the selection of reference materials for medical device testing primarily in biological test systems primarily in accordance with one or more parts of the ISO 10993 series. Specifically, this document addresses the following: — test sample selection; — selection of representative portions from a medical device; — test sample preparation; — experimental controls; — selection of, and require...view more

    • sale 15% off
    • Standard
      22 pages
      French language
    • sale 15% off
    • Draft
      26 pages
      English language
    • sale 15% off
    • Draft
      28 pages
      French language
    • sale 15% off
    • Standard
      21 pages
      English language

This document specifies the procedure for the assessment of medical devices and their constituent materials with regard to their potential to produce irritation. The tests are designed to predict and classify the irritation potential of medical devices, materials or their extracts according to ISO 10993‑1 and ISO 10993‑2. This document includes: — pre-test considerations for irritation, including in silico and in vitro methods for dermal exposure; — details of in vitro and in vivo irritation tes...view more

    • sale 15% off
    • Standard
      60 pages
      English language
    • sale 15% off
    • Standard
      62 pages
      French language
    • sale 15% off
    • Draft
      65 pages
      English language
    • sale 15% off
    • Draft
      65 pages
      French language

This document specifies a framework for the identification, and if necessary, quantification of
constituents of a medical device, allowing the identification of biological hazards and the estimation
and control of biological risks from material constituents, using a generally stepwise approach to the
chemical characterization which can include one or more of the following:
— the identification of its materials of construction (medical device configuration);
— the characterization of the mat...
view more

    • sale 10% off
    • Standard
      81 pages
      English language
    • e-Library read for
      1 day
    • sale 10% off
    • Draft
      69 pages
      English language
    • e-Library read for
      1 day

This document specifies requirements for controls on the sourcing, collection, and handling (which includes storage and transport) of animals and tissues for the manufacture of medical devices utilizing materials of animal origin other than in vitro diagnostic medical devices. It applies where required by the risk management process as described in ISO 22442‑1. NOTE Selective sourcing is especially important for transmissible spongiform encephalopathy (TSE) risk management, i.e. when utilising a...view more

    • sale 15% off
    • Standard
      15 pages
      English language
    • sale 15% off
    • Standard
      17 pages
      French language
    • sale 15% off
    • Draft
      18 pages
      English language

This document applies to medical devices other than in vitro diagnostic medical devices manufactured utilizing materials of animal origin, which are non-viable or have been rendered non-viable. It specifies, in conjunction with ISO 14971, a procedure to identify the hazards and hazardous situations associated with such devices, to estimate and evaluate the resulting risks, to control these risks, and to monitor the effectiveness of that control. Furthermore, it outlines the decision process for ...view more

    • sale 15% off
    • Standard
      26 pages
      English language
    • sale 15% off
    • Standard
      28 pages
      French language
    • sale 15% off
    • Draft
      29 pages
      English language

This document addresses good clinical practice for the design, conduct, recording and reporting of clinical investigations carried out in human subjects to assess the clinical performance or effectiveness and safety of medical devices. For post-market clinical investigations, the principles set forth in this document are intended to be followed as far as relevant, considering the nature of the clinical investigation (see Annex I). This document specifies general requirements intended to — protec...view more

    • sale 15% off
    • Standard
      90 pages
      French language
    • sale 15% off
    • Standard
      83 pages
      English language
    • sale 15% off
    • Standard
      90 pages
      French language
    • sale 15% off
    • Standard
      83 pages
      English language
    • sale 15% off
    • Standard
      90 pages
      French language
    • sale 15% off
    • Draft
      91 pages
      English language

This document provides a compilation of parameters and test methods that can be useful for the identification and evaluation of the physical, i.e. physico‑chemical, morphological and topographical (PMT) properties of materials in finished medical devices. Such an assessment is limited to those properties that are relevant to biological evaluation and the medical device's intended use (clinical application and duration of use) even if such properties overlap with clinical effectiveness. This docu...view more

    • sale 15% off
    • Technical specification
      13 pages
      English language

This document specifies a framework for the identification, and if necessary, quantification of constituents of a medical device, allowing the identification of biological hazards and the estimation and control of biological risks from material constituents, using a generally stepwise approach to the chemical characterization which can include one or more of the following: — the identification of its materials of construction (medical device configuration); — the characterization of the material...view more

    • sale 15% off
    • Standard
      66 pages
      English language
    • sale 15% off
    • Standard
      72 pages
      French language
    • sale 15% off
    • Standard
      5 pages
      English language
    • sale 15% off
    • Standard
      5 pages
      French language
    • sale 15% off
    • Standard
      16 pages
      French language
    • sale 15% off
    • Standard
      15 pages
      English language

This document provides general principles for the systematic evaluation of the potential and observed degradation of medical devices through the design and performance of in vitro degradation studies. Information obtained from these studies can be used in the biological evaluation described in the ISO 10993 series. This document is applicable to both materials designed to degrade in the body as well as materials that are not intended to degrade. This document is not applicable to: a) the evaluat...view more

    • sale 15% off
    • Standard
      11 pages
      English language
    • sale 15% off
    • Standard
      10 pages
      French language

This document describes one reference method, broth micro-dilution, for determination of MICs. The MIC can be a guide for the clinician, and reflects the activity of the drug under the described test conditions, by taking into account other factors, such as drug pharmacology, pharmacokinetics, or bacterial resistance mechanisms. This allows categorisation of bacteria as "susceptible" (S), "intermediate" (I), or "resistant" (R). In addition, MIC distributions can be used to define wild type or no...view more

    • sale 15% off
    • Standard
      19 pages
      French language
    • sale 15% off
    • Standard
      19 pages
      English language

This document describes the basis for, selection of, and general applicability of a threshold of toxicological concern (TTC) value for a constituent present in/on a medical device or released from a medical device. The TTC values in this document can be used for: — comparing to a maximum concentration of an identified or unidentified constituent in an extract (see ISO 10993-18); — supporting toxicological equivalence; — comparing to a maximum exposure dose estimate of an identified constituent (...view more

    • sale 15% off
    • Technical specification
      7 pages
      English language

This document specifies test methods for the evaluation of biological effects of medical devices used in
dentistry. It includes testing of pharmacological agents that are an integral part of the device under test.
This document does not cover testing of materials and devices that do not come into direct or indirect
contact with the patient's body.

    • sale 10% off
    • Standard
      52 pages
      English language
    • e-Library read for
      1 day

This document specifies: — the general principles governing the biological evaluation of medical devices within a risk management process; — the general categorization of medical devices based on the nature and duration of their contact with the body; — the evaluation of existing relevant data from all sources; — the identification of gaps in the available data set on the basis of a risk analysis; — the identification of additional data sets necessary to analyse the biological safety of the medi...view more

    • sale 15% off
    • Standard
      44 pages
      French language
    • sale 15% off
    • Standard
      41 pages
      English language

This part of ISO 10993 describes the procedure for the assessment of medical devices and their constituent
materials with regard to their potential to produce irritation and skin sensitization.
This part of ISO 10993 includes:
a) pretest considerations for irritation, including in silico and in vitro methods for dermal exposure;
b) details of in vivo (irritation and sensitization) test procedures;
c) key factors for the interpretation of the results.
Instructions are given in Annex A for t...
view more

    • sale 10% off
    • Standard
      81 pages
      English language
    • e-Library read for
      1 day

This document specifies:
— the general principles governing the biological evaluation of medical devices within a risk management process;
— the general categorization of medical devices based on the nature and duration of their contact with the body;
— the evaluation of existing relevant data from all sources;
— the identification of gaps in the available data set on the basis of a risk analysis;
— the identification of additional data sets necessary to analyse the biological safety of the...
view more

    • sale 10% off
    • Standard
      50 pages
      English language
    • e-Library read for
      1 day
    • sale 10% off
    • Draft
      51 pages
      English language
    • e-Library read for
      1 day

ISO 10993-11:2017 specifies requirements and gives guidance on procedures to be followed in the evaluation of the potential for medical device materials to cause adverse systemic reactions.

    • sale 10% off
    • Standard
      81 pages
      English language
    • e-Library read for
      1 day

This document provides principles on designing and performing toxicokinetic studies relevant to
medical devices. Annex A describes the considerations for inclusion of toxicokinetic studies in the
biological evaluation of medical devices.

    • sale 10% off
    • Standard
      26 pages
      English language
    • e-Library read for
      1 day

ISO 10993-4:2017 specifies general requirements for evaluating the interactions of medical devices with blood.
It describes
a) a classification of medical devices that are intended for use in contact with blood, based on the intended use and duration of contact as defined in ISO 10993‑1,
b) the fundamental principles governing the evaluation of the interaction of devices with blood,
c) the rationale for structured selection of tests according to specific categories, together with the princip...
view more

    • sale 10% off
    • Standard
      83 pages
      English language
    • e-Library read for
      1 day

ISO 10993-16:2017 provides principles on designing and performing toxicokinetic studies relevant to medical devices. Annex A describes the considerations for inclusion of toxicokinetic studies in the biological evaluation of medical devices.

    • sale 10% off
    • Standard
      26 pages
      English language
    • e-Library read for
      1 day

ISO 10993-4:2017 specifies general requirements for evaluating the interactions of medical devices with blood.
It describes
a) a classification of medical devices that are intended for use in contact with blood, based on the intended use and duration of contact as defined in ISO 10993‑1,
b) the fundamental principles governing the evaluation of the interaction of devices with blood,
c) the rationale for structured selection of tests according to specific categories, together with the princip...
view more

    • sale 10% off
    • Standard
      83 pages
      English language
    • e-Library read for
      1 day

ISO 10993-11:2017 specifies requirements and gives guidance on procedures to be followed in the evaluation of the potential for medical device materials to cause adverse systemic reactions.

    • sale 15% off
    • Standard
      32 pages
      French language
    • sale 15% off
    • Standard
      29 pages
      English language

ISO/TR 10993-22:2017 describes considerations for the biological evaluation of medical devices that are composed of or contain nanomaterials. In addition, this guidance can also be used for the evaluation of nano-objects generated as products of degradation, wear, or from mechanical treatment processes (e.g. in situ grinding, polishing of medical devices) from (components of) medical devices that are manufactured not using nanomaterials. ISO/TR 10993-22:2017 includes considerations on the: - cha...view more

    • sale 15% off
    • Technical report
      61 pages
      English language
    • sale 15% off
    • Technical report
      65 pages
      French language

ISO 10993-16:2017 provides principles on designing and performing toxicokinetic studies relevant to medical devices. Annex A describes the considerations for inclusion of toxicokinetic studies in the biological evaluation of medical devices.

    • sale 15% off
    • Standard
      13 pages
      English language
    • sale 15% off
    • Standard
      14 pages
      French language

ISO 10993-4:2017 specifies general requirements for evaluating the interactions of medical devices with blood. It describes a) a classification of medical devices that are intended for use in contact with blood, based on the intended use and duration of contact as defined in ISO 10993‑1, b) the fundamental principles governing the evaluation of the interaction of devices with blood, c) the rationale for structured selection of tests according to specific categories, together with the principles ...view more

    • sale 15% off
    • Standard
      74 pages
      French language
    • sale 15% off
    • Standard
      69 pages
      English language

This part of ISO 10993 specifies test methods for the assessment of the local effects after implantation
of biomaterials intended for use in medical devices.
This part of ISO 10993 applies to materials that are
— solid and non-absorbable,
— non-solid, such as porous materials, liquids, gels, pastes, and particulates, and
— degradable and/or absorbable, which may be solid or non-solid.
The test sample is implanted into a site and animal species appropriate for the evaluation of the
biologi...
view more

    • sale 10% off
    • Standard
      42 pages
      English language
    • e-Library read for
      1 day

ISO 10993-6:2016 specifies test methods for the assessment of the local effects after implantation of biomaterials intended for use in medical devices.
ISO 10993-6:2016 applies to materials that are
- solid and non-absorbable,
- non-solid, such as porous materials, liquids, gels, pastes, and particulates, and
- degradable and/or absorbable, which may be solid or non-solid.
The test sample is implanted into a site and animal species appropriate for the evaluation of the biological safety of ...
view more

    • sale 10% off
    • Standard
      42 pages
      English language
    • e-Library read for
      1 day

ISO 10993-6:2016 specifies test methods for the assessment of the local effects after implantation of biomaterials intended for use in medical devices. ISO 10993-6:2016 applies to materials that are - solid and non-absorbable, - non-solid, such as porous materials, liquids, gels, pastes, and particulates, and - degradable and/or absorbable, which may be solid or non-solid. The test sample is implanted into a site and animal species appropriate for the evaluation of the biological safety of the m...view more

    • sale 15% off
    • Standard
      30 pages
      French language
    • sale 15% off
    • Standard
      29 pages
      English language

ISO/TS 16782:2016 provides a standard description of the physical properties of dehydrated Mueller-Hinton broth (dMHB) and Mueller-Hinton agar (dMHA) and performance criteria by which manufacturers can assess the performance characteristics of their production lots of dMHA and dMHB. Production lots of broth or agar can then be utilized by all users, including in vitro susceptibility testing device manufacturers, as the test medium for performance of antimicrobial susceptibility testing. ISO/TS 1...view more

    • sale 15% off
    • Technical specification
      21 pages
      English language

There are differences between the views of regulatory bodies on the subject of genotoxicity testing. The purpose of this ISO/TR 10993-33: 2015 is to provide background information to facilitate the selection of tests and guidance on the performance of tests.

    • sale 15% off
    • Technical report
      47 pages
      English language

This part of ISO 10993 specifies strategies for risk estimation, selection of hazard identification tests
and risk management, with respect to the possibility of the following potentially irreversible biological
effects arising as a result of exposure to medical devices:
— genotoxicity;
— carcinogenicity;
— reproductive and developmental toxicity.
This part of ISO 10993 is applicable when the need to evaluate a medical device for potential genotoxicity,
carcinogenicity, or reproductive to...
view more

    • sale 10% off
    • Standard
      46 pages
      English language
    • e-Library read for
      1 day

ISO 10993-3:2014 specifies strategies for risk estimation, selection of hazard identification tests and risk management, with respect to the possibility of the following potentially irreversible biological effects arising as a result of exposure to medical devices:
genotoxicity;
carcinogenicity;
reproductive and developmental toxicity.
ISO 10993-3:2014 is applicable when the need to evaluate a medical device for potential genotoxicity, carcinogenicity, or reproductive toxicity has been es...
view more

    • sale 10% off
    • Standard
      46 pages
      English language
    • e-Library read for
      1 day

ISO 10993-3:2014 specifies strategies for risk estimation, selection of hazard identification tests and risk management, with respect to the possibility of the following potentially irreversible biological effects arising as a result of exposure to medical devices: genotoxicity; carcinogenicity; reproductive and developmental toxicity. ISO 10993-3:2014 is applicable when the need to evaluate a medical device for potential genotoxicity, carcinogenicity, or reproductive toxicity has been establish...view more

    • sale 15% off
    • Standard
      37 pages
      French language
    • sale 15% off
    • Standard
      34 pages
      English language
    • sale 15% off
    • Standard
      34 pages
      English language

This part of ISO 10993 describes the procedure for the assessment of medical devices and their constituent materials with regard to their potential to produce irritation and skin sensitization. This part of ISO 10993 includes: a) pretest considerations for irritation, including in silico and in vitro methods for dermal exposure; b) details of in vivo (irritation and sensitization) test procedures; c) key factors for the interpretation of the results. Instructions are given in Annex A for the pre...view more

    • sale 10% off
    • Standard
      78 pages
      English language
    • e-Library read for
      1 day

2013-07-30 EMA: Redrafted Annex Z included in a new edition to EN ISO 10993-10:2010 and to be offered to the EC for citation with the next dispatch of titles

    • sale 10% off
    • Standard
      78 pages
      English language
    • e-Library read for
      1 day

This part of ISO 10993 specifies requirements and gives guidance on the procedures to be followed in the preparation of samples and the selection of reference materials for medical device testing in biological systems in accordance with one or more parts of ISO 10993. Specifically, this part of ISO 10993 addresses the following: - test sample selection; - selection of representative portions from a device; - test sample preparation; - experimental controls; - selection of, and requirements, for ...view more

    • sale 10% off
    • Standard
      30 pages
      English language
    • e-Library read for
      1 day

ISO 10993-12:2012 specifies requirements and gives guidance on the procedures to be followed in the preparation of samples and the selection of reference materials for medical device testing in biological systems in accordance with one or more parts of ISO 10993. Specifically, ISO 10993-12:2012 addresses the following:
test sample selection;
selection of representative portions from a device;
test sample preparation;
experimental controls;
selection of, and requirements for, reference m...
view more

    • sale 10% off
    • Standard
      30 pages
      English language
    • e-Library read for
      1 day

ISO 10993-12:2012 specifies requirements and gives guidance on the procedures to be followed in the preparation of samples and the selection of reference materials for medical device testing in biological systems in accordance with one or more parts of ISO 10993. Specifically, ISO 10993-12:2012 addresses the following: test sample selection; selection of representative portions from a device; test sample preparation; experimental controls; selection of, and requirements for, reference materials;...view more

    • sale 15% off
    • Standard
      24 pages
      French language
    • sale 15% off
    • Standard
      20 pages
      English language

This International Standard specifies requirements and guidance for processing practices and managing risk associated with viable cellular components of products regulated as medicinal products, biologics, medical devices and active implantable medical devices, or combinations thereof. It covers viable human materials of autologous as well as allogeneic human origin, obtained from living or deceased donors. For manufacturers of medical products containing viable cells of human origin, this Inter...view more

    • sale 15% off
    • Standard
      48 pages
      English language

ISO/TR 22442-4:2010 offers suggestions for designing and conducting validation assays to help determine if processes used in the manufacture of medical devices derived from non-viable animal tissues might serve to reduce the risk of iatrogenic transmission of transmissible spongiform encephalopathies (TSEs). The TSE-removal methods used to process animal tissues should also reduce the risk of transmitting TSE infections via non-viable tissues of human origin; this Technical Report does not addre...view more

    • sale 15% off
    • Technical report
      14 pages
      English language

This part of ISO 10993 provides general requirements for the design of tests in a simulated environment for identifying and quantifying degradation products from finished polymeric medical devices ready for clinical use. This part of ISO 10993 describes two test methods to generate degradation products, an accelerated degradation test as a screening method and a real-time degradation test in a simulated environment. For materials that are intended to polymerize in situ, the set or cured polymer ...view more

    • sale 10% off
    • Standard
      25 pages
      English language
    • e-Library read for
      1 day

ISO 10993-10:2010 describes the procedure for the assessment of medical devices and their constituent materials with regard to their potential to produce irritation and skin sensitization. ISO 10993-10:2010 includes: pretest considerations for irritation, including in silico and in vitro methods for dermal exposure; details of in vivo (irritation and sensitization) test procedures; key factors for the interpretation of the results. Instructions are given for the preparation of materials specific...view more

    • sale 15% off
    • Standard
      69 pages
      French language
    • sale 15% off
    • Standard
      67 pages
      English language

ISO 10993‑13:2010 provides general requirements for the design of tests in a simulated environment for identifying and quantifying degradation products from finished polymeric medical devices ready for clinical use.
ISO 10993‑13:2010 describes two test methods to generate degradation products, an accelerated degradation test as a screening method and a real-time degradation test in a simulated environment. For materials that are intended to polymerize in situ, the set or cured polymer is used f...
view more

    • sale 10% off
    • Standard
      25 pages
      English language
    • e-Library read for
      1 day

ISO 10993‑13:2010 provides general requirements for the design of tests in a simulated environment for identifying and quantifying degradation products from finished polymeric medical devices ready for clinical use. ISO 10993‑13:2010 describes two test methods to generate degradation products, an accelerated degradation test as a screening method and a real-time degradation test in a simulated environment. For materials that are intended to polymerize in situ, the set or cured polymer is used fo...view more

    • sale 15% off
    • Standard
      15 pages
      French language
    • sale 15% off
    • Standard
      14 pages
      English language

This part of ISO 10993 provides general principles for the systematic evaluation of the potential and observed biodegradation of medical devices and for the design and performance of biodegradation studies. Information obtained from these studies can be used in the biological evaluation described in the ISO 10993 series. This part of ISO 10993 considers both non-resorbable and resorbable materials. This part of ISO 10993 is not applicable to: a) evaluation of degradation which occurs by purely m...view more

    • sale 10% off
    • Standard
      20 pages
      English language
    • e-Library read for
      1 day

ISO 10993-9:2008 provides general principles for the systematic evaluation of the potential and observed biodegradation of medical devices and for the design and performance of biodegradation studies. Information obtained from these studies can be used in the biological evaluation described in the ISO 10993 series. ISO 10993-9:2008 considers both non-resorbable and resorbable materials.

    • sale 10% off
    • Standard
      20 pages
      English language
    • e-Library read for
      1 day